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Prepregnancy overweight or obesity and excessive gestational weight gain have been associated with increased risk of maternal
and neonatal complications. Moreover, oﬀspring from obese women are more likely to develop obesity, diabetes mellitus, and car
diovascular diseases in their lifetime. Gestational diabetes mellitus (GDM) is one of the most common complications associated
with obesity and appears to have a direct impact on the future metabolic health of the child. Fetal programming of metabolic func-
tion induced by obesity and GDM may have intergenerational eﬀect and thus perpetuate the epidemic of cardiometabolic condi-
tions. The present paper thus aims at discussing the impact of maternal obesity and GDM on the developmental programming of
obesity and metabolic disorders in the oﬀspring. The main interventions designed to reduce maternal obesity and GDM and their
ability to break the vicious circle that perpetuates the transmission of obesity and metabolic conditions to the next generations are
also addressed.
1.Introduction
Obesity is a major public health problem that was identiﬁed
as an epidemic by the World Health Organization [1]. The
US Centers for Disease Control and Prevention estimates
that 34% of adults 20 years of age and over are obese (body
mass index (BMI) above 30kg/m2), in addition to another
34% who are classiﬁed as overweight (BMI 25–30kg/m2)f o r
a total of over two-thirds of Americans with inappropriately
high body weight. Women are thus more likely to enter preg-
nancy overweight or obese nowadays. In fact, among a sam-
ple of 75.000 delivering women recruited all over USA, 20%
were obese [2]. Moreover, oﬀspring from obese women is
more likely to develop obesity, diabetes mellitus, and cardio
vascular diseases in their lifetime, often at a younger age [3].
Thispaperwillthusfocusonmaternalobesityandgestation-
al diabetes mellitus (GDM) as determinants for the de-
velopmental programming of obesity and metabolic disor-
ders in the oﬀspring. We are also presenting the main
interventions tested to reduce those two important maternal
burdens and how they can break the vicious circle that per-
petuates the transmission of obesity and metabolic condi-
tions to the next generations.
2.GestationalWeight and
Metabolic Complications
2.1. Appropriate Gestational Weight Gain. Due in part to con
cerns about the increasing prevalence of obesity in reproduc
tive-age women, the Institute of Medicine (IOM; which is a
nonproﬁt American organization serving as adviser to the
nation to improve health http://www.iom.edu/About-IOM
.aspx) recently released new guidelines (Table 1) for gesta-
tional weight gain to better reﬂect the growing body of
evidenceinfavourofloweringweightgainrecommendations
f o ro v e r w e i g h ta n do b e s ep r e g n a n tw o m e n[ 4]. In com-
parison to the previous 1990 guidelines, 1 out of 6 women
were diﬀerently classiﬁed using the new 2009 guidelines, that
is, fewer pregnant women were classiﬁed as underweight,2 Experimental Diabetes Research
Table 1: Recommendation given by the Institute of Medicine in
2009 for appropriate gestational weight gain based on preconcep-
tion body mass index (BMI).
Preconception
BMI (kg/m2)
Total weight gain during
pregnancy
Weight gain during
2nd and 3rd trimesters
(per week)
<18.5 28–40lbs/13–18 kg 1.0–1.3lbs/0.5-0.6kg
18.5–24.9 25–35lbs/11–16 kg 0.8–1.0lbs/0.4-0.5kg
25.0–29.9 15–25lbs/7–11kg 0.5–0.7lbs/0.2-0.3kg
≥30.0 11–20lbs/5–9kg 0.4–0.6lbs/0.2-0.3kg
Adapted from [4].
normal weight, or obese, and more as overweight [5]. More-
over, 17.1% of appropriate gainers based on 1990 recom-
mendations would now be classiﬁed as overgainers [5].
As some people were worried by these severe guidelines,
Einerson et al. showed, in a retrospective study, that the new
recommended weight gain thresholds were safe for both the
mothers and the developing child [6]. In fact, those new
weight gain thresholds were clinically eﬀective in reducing
caesarean and pregnancy-induced hypertension, and no
increase in the proportion of low-birth weight infants was
recorded in 691 participants as compared to the proportion
observedinobesewomenwithappropriateweightgainbased
on 1990 recommendations [6].
However, according to these new guidelines, Weisman
et al. reported from a population-based cohort study that
40% of normal weight women exceeded the IOM recom-
mendations, while excess weight gain was observable in 63%
and 62% of overweight and obese women, respectively, [7].
The same group also showed that prepregnancy overweight
women were 3 times more likely to exceed the recommended
weight gain than normal-weight women [7]. In a recent
observationalstudyincluding14430-weekpregnantwomen,
33% of participants reported an excessive gestational weight
gain [8]. Factors associated with excess weight gain included
prepregnancy overweight as well as low physical activity
and high-food intake during pregnancy, as reported by the
participants. On the other hand, some factors seem to be
associated with lower risk of excess weight gain such as men-
arche occurring at an older age and increased hours of sleep
[8]. In summary, these results suggest that pregnant women
frequently exceed the recommended gestational weight gain,
but it may be feasible to optimize weight loss by promoting
physical activity and healthy eating among women of repro-
ductive age.
2.2. Obesity-Associated Obstetrical and Neonatal Complica-
tions. Prepregnancy overweight or obesity andexcessivepre-
gnancy weight gain both have been independently associated
with increased risk of complications. Indeed, several studies
demonstrated the association between increased maternal
BMIandhigherrisksofobstetricandneonatalcomplications
[9]. Obese women are at increased risk of complications over
the whole spectrum of peripregnancy period: antepartum,
intrapartum, intraoperative, postoperative, and postpartum
(forreview,see[10,11]).Brieﬂy,atthematernallevel,obesity
increases the risk of menstrual disorders [12], infertility
[13], miscarriage [14], pregnancy-induced hypertension and
preeclampsia [15], GDM [16], induction of labour and cae-
sarean section [17], and haemorrhage, infection, and venous
thromboembolism. At the level of the newborn, maternal
obesity is also associated with many complications: macro-
somia (deﬁned as a birth weight >4.000g), shoulder dystocia
[18], fetal distress, and perinatal morbidity/mortality (for
review, see [10]). Still birth [19]a n db i r t hd e f e c t ss u c ha s
hydrocephaly, omphalocele, heart, and neural tube defects
[20, 21] are among the disastrous neonatal outcomes that
have been associated to maternal obesity (identiﬁed as the
top modiﬁable risk factor). In a large population-based
retrospective cohort study [22] including singleton macro-
somic live births infants, it was demonstrated that the overall
risk of obstetrical complications was increased almost 3-
fold in obese (BMI ≥ 30kg/m2) as compared to nonobese
mothers (BMI < 30kg/m2) (17% versus 6%). Macrosomic
neonates born from obese mothers were at increased risk
of birth injury, hyaline membrane disease, meconium aspi-
ration syndrome, and more required assisted ventilation.
Project Viva study [23] analysed data from 2.012 recruited
mother-child pairs in order to determine the level of gesta-
tional weight gain which was associated with the lowest pre-
dicted prevalence of adverse obstetrical and neonatal out-
comes. They showed that the mean total gestational weight
gain was 15.6kg. The lowest predicted outcome prevalence
o c c u r r e dw i t haw e i g h tg a i no f1 1 . 2k gf o rw o m e nw i t hp r e -
pregnancy BMI in the normal range, with a weight loss of
1.2kgforoverweight women,and withaweightloss of 7.6kg
for obese participants.
Weightgainbetweeneachpregnancy(ornotreturningto
prepregnancy body weight) is also associated with increased
adverse health issues. Indeed, a large population-based Swe-
dish cohort study including women who had 2 consecutive
live-birth pregnancies robustly showed that in comparison
to women whose prepregnancy BMI did not change much
between both pregnancies (−1 to 0.9 BMI points), mothers
who gained more than 3 units of BMI between pregnancies
increased by 30% to 110% their adjusted estimated risks of
important complications (odds ratio of 1.78 for preeclamp-
sia, 1.76 for gestational hypertension, 2.09 for GDM, 1.32
for caesarean delivery, 1.63 for stillbirth, and 1.87 for large-
for-gestational-age birth). These risks were associated with
the amount of weight change between pregnancies, and this
association was also noted in women who had a healthy
prepregnancy BMI for both pregnancies [24]. This example
underscores the point that women do not necessarily need to
be in transition from a normal BMI to overweight or obese-
BMI, but those relatively small increases in BMI were asso-
ciated with adverse outcomes. Collectively, these data em-
phasize the importance of adequate gestational weight gain
in pregnant obese women, as recently recommended by
the Institute of Medicine, in order to avoid maternal and
neonatal complications.Experimental Diabetes Research 3
3.GestationalDiabetesMellitus(GDM)
3.1. Deﬁnition and Diagnosis. According to the International
Association of Diabetes and Pregnancy Study Groups
(IADPSG) [25], GDM is deﬁned as an impaired glucose
tolerance that is ﬁrst recognized during pregnancy, and it
occurs in approximately 7% of pregnancies in the USA. Bas-
ed on a meta-analysis, GDM incidence varies from 1.3% to
19.9%dependingonscreeninganddiagnosticguidelinesthat
are followed and the study populations [26]. In 2010, new
recommendationsbroughtupbytheIADPSGwereapproved
to diagnose GDM [27]. This guideline suggests to screen
with a 75 g oral glucose tolerance test (OGTT) without prior
glucose challenge and to diagnose GDM if the fasting plasma
glucose is ≥5.1mmol/L and/or the 1-hour postload plasma
glucose is ≥10.0mmol/L and/or the 2-hour postload plasma
glucose is ≥8.5mmol/L.
3.2. Pathophysiology of Gestational Diabetes. Normal preg-
nancy is characterized by an insulin-resistant state in order
to fulﬁll the increasing metabolic demand ordered by the
developingfoetus.Thephysiologicresultofinsulinresistance
is thus an increase in insulin secretion by the pancreatic
β-cells in order to compensate for reduced insulin action.
However, women who fail to do so will progressively develop
GDM [28]. In GDM, insulin resistance and the relative
insulindeﬁciencyduetopancreaticβ-celldysfunctionarethe
primary metabolic changes. As gluconeogenesis increases, as
a result of hepatic insulin resistance, and relative insulin deﬁ-
ciency is exacerbated, hyperglycemia becomes more severe.
However, many questions still remain in order to adequately
understand the mechanisms by which GDM takes place. It is
not in the scope of this paper to discuss the pathophysiology
of GDM, but mechanisms presently under investigation in-
clude the role of genetic factors, glucose transport activity,
adipokines defects, and adipose tissue dysregulation (for
review, see [29]).
3.3. Relationship between Gestational Diabetes and Maternal
Obesity. Importantly, overweight and obese women are
more insulin resistant than their lean counterparts and also
more prone to β-cell dysfunction [30], which is mainly due
to adipose tissue dysregulation and largely inﬂuenced by
ethnicity and age [31]. For these reasons, obesity is an im-
portant determinant of the long-term risk of developing
type 2 diabetes in genetically predisposed individuals. Con-
sequently,overweightorobesewomenbegintheirpregnancy
withinsulinresistanceandincreasedpredispositionforβ-cell
dysfunction,whichcouldresultinGDMwiththepregnancy-
related progression of insulin resistance. An excess of weight
gain during pregnancy would further worsen these phenom-
ena and increase the risk of GDM as well, even in women
with normal prepregnancy weight.
GDM is thus one of the most common obstetrical com-
plications associated with obesity. The Project Viva study ex-
plored the relationship of trimester-speciﬁc rate of weight
gain with impaired glucose tolerance during pregnancy [32].
In this study, the authors showed that the median rate of
weight gain during early pregnancy (less than 13 weeks) was
of 0.22kg/week, while it was of 0.50kg/week during mid-
pregnancy. Accordingly, they showed that women who gain-
ed more than 0.22kg/week during early pregnancy increased
by 40% their odds of developing impaired glucose tolerance
even if they gained more than 0.50kg/week during midpreg-
nancy. Moreover, women who were high gainers during early
and midpregnancy doubled their odds for impaired glucose
tolerance diagnosed during 2nd trimester [32]. By analyzing
data from 7 states using the Pregnancy Risk Assessment
Monitoring System (PRAMS), Kim et al. showed that the
proportionofGDMthatwasattributabletooverweight,obe-
sity and extreme obesity was, respectively, of 15.4%, 9.7%,
and 21.1% [33]. The overall population-attributable fraction
foroverweight/obesity,aftersubtractingwomenwithnormal
weight, was 46.2%. However, it was recently shown in 36.597
Canadian women, that the increased incidence of glucose
disorders during pregnancy was not explained by higher
maternal prepregnancy adiposity [34]. These contradictory
results between studies may be explained by diﬀerent popu-
lation ethnic background and patterns of gestational weight
gain, which are important factors to consider in the interpre-
tation of studies on GDM.
3.4. Gestational Diabetes-Associated Neonatal Complications.
Excessive fetal growth is probably the most frequent and
important outcome of GDM. It was long known that the
nutritionalstatusofthemotherandaccordinglyherglycemic
control may directly be in relation with her infant growth.
This concept was based on studies reporting that macro-
somia occurs as a result of fetal insulin hypersecretion in
response to the mother rise of glycemia [35]. On the other
hand, it was shown in pregnant rats that maternal hypogly-
cemia generates intrauterine growth restriction of the oﬀ-
spring, which was accompanied by fetal hypoglycemia and
hypoinsulinemia[36].Accordingly,whilethemotherglucose
can diﬀuse through the placental barrier [37], maternal
insulin cannot [38]. So, in situation of mother hyperglyce-
mia, the foetus is consequently exposed to important quanti-
ties of glucose. In order to regulate its own glucose home-
ostasis, the foetus increases its insulin secretion, which is an
important growth factor in the developing foetus. The foetus
is thus more exposed to insulin leading to excessive growth
and later programming of metabolic functions [39]. Addi-
tionally to macrosomia, many of the perinatal complications
that have been associated with obesity are also known to be
associated with GDM [40]. These include increased risks for
preeclampsia, caesarean, stillbirth, spontaneous abortion
and congenital malformations.
The question thus arising is whether the increased risk
of adverse perinatal outcome in obese women is related to
obesity per se or the increased risk of developing GDM. The
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
study attempted to address such question. This trial enrolled
more than 23.000 mothers and baby pairs. This study
showed a strong linear association between fasting and post-
challenge glucose and the incidence of macrosomia and neo-
nataladiposity[41].Theyalsoclearlyshowedthattheimpact4 Experimental Diabetes Research
of hyperglycaemia on the foetus was present at a much
lower glucose concentration than previously thought [42].
This study thus suggests that complications may arise even
with gestational glucose levels below the thresholds of
GDM. Furthermore, a retrospective study of 413 women
with GDM or impaired glucose tolerance found that fetal
macrosomiawasnotassociatedwithmaternalglucosevalues,
except fasting glucose levels between 32 and 35 weeks of
pregnancy, while maternal obesity was a strong risk factor
for macrosomia throughout these pregnancies [43]. On the
other hand, a recent study suggested that pre-GDM was
a stronger predictor of increase in birth defect prevalence
than maternal obesity in their study population [44]. So
the question of whether adverse perinatal outcomes in obese
pregnant women are due to GDM (clinical or subclinical) is
still unanswered and remains an open ﬁeld for research.
4. Fetal Programmingof Adult Diseases
In addition to the previously cited neonatal complication in-
duced by maternal obesity and GDM, oﬀspring born from
these women are more likely to develop health problems
later in life. In fact, in the early 1990, David Barker pub-
lished a paper in the British Medical Journal entitled “The
fetal and infants origin of adult disease. The womb may be-
more important than the home” [45]. This concept of fetal
programming or developmental plasticity states that an
insult or stress, occurring during period of maximal growth
and development of an organ, overcome normal physiolog-
ical processes. In such situation, the organ needs to adapt
to its new environment, which then conducts to adapta-
tion/reprogramming of functions of this organ [46]. In his
1990 paper, Barker was visionary as he stated that “research
should be redirected towards the intrauterine environment
rather than the environment in later childhood-housing,
family income, diet, and other inﬂuences” [45].
Of the ﬁrst studies that were conducted to support the
concept of fetal programming, maternal nutrition, either
deﬁcient or excessive, during pregnancy was pinpoint to
have various and often deleterious eﬀects on the oﬀspring.
Of the most critical and cited examples are the Dutch
FamineandsomestudiesconductedinPimaIndians.During
World War II, food supply and calories intake were dra-
matically restricted in the Netherlands. This dark period
was called the Dutch Hunger Winter. Consequently, foetuses
thatwereexposedtothisfamineduringmid-tolatepregnan-
cies had small placentas, were born small-for-gestational
age when compared to those foetuses exposed in the early
phaseofpregnancy.Asthesefoetusesbecameadults,thepro-
portionofindividualssuﬀeringfromglucoseintoleranceand
insulin resistance was greater among those whose fetal insult
occurred during mid- to late pregnancy. However, athero-
genic lipid proﬁle, increased BMI and raised cardiovascular
riskweregreateramongthosewhowereexposedduringearly
pregnancy [47].
Pima Indians are a recognized population for increased
prevalence of obesity and type 2 diabetes particularly since
their nutritional income was greatly modiﬁed by a typical
Westernized diet in the past few decades [48]. In comparison
to infants born from mothers who developed diabetes after
pregnancy, those born from women who had diabetes before
pregnancy were more prone to obesity, had higher blood
glucose and glycated haemoglobin levels, lower C-HDL con-
centration and were more likely to develop diabetes during
their childhood [49, 50]. These results suggests that the
period when the fetal insult occur is very determinant in the
reprogramming of functions and that either a poor or a too
rich maternal nutrition can lead to a U-shaped association
for risk of future adult diseases, with both low and high birth
weight being associated with risk of adverse health conse-
quences.
5. Long-Term Health Effect of Gestational
Obesityon the Offspring
5.1. Clinical Studies. Major factors associated with fetal adi-
posity are maternal prepregnancy BMI and weight gain dur
ing pregnancy [51]. Many studies have reported that mother
prepregnancy BMI and gestational weight gain were pos-
itively associated with oﬀspring BMI at birth as well as
during infancy, childhood and early adulthood [52–56]. A
recent retrospective study of 8.400 children in the US found
that children born from obese mothers were twice as likely
to be obese at 24 months of age [57]. It was shown that at
time of birth, infants born from obese women had increased
adiposity, homeostasis model assessment of insulin resis-
tance (HOMA-IR, a fasting index estimating insulin resis-
tance), cord blood leptin and interleukin-6 (IL-6) concentra
tions. Moreover, fetal adiposity and mother prepregnancy
BMI were both highly correlated with fetal HOMA-IR [58].
In a recent prospective cohort of 146.894 oﬀspring from
136.050 families, Lawlor and colleagues explored whether
and how maternal weight gain is associated with increased
oﬀspring BMI at 18 years old. They showed that maternal
weight was positively associated to young adult adiposity.
They also provided evidences that oﬀspring adiposity later in
life was mostly explained by familial characteristics in those
born to normal weight mothers, but mainly inﬂuenced by
intrauterine mechanisms in overweight and obese mothers
[59]. Moreover, as caesarean is one important adverse
outcome associated with maternal obesity, it was shown that
oﬀspring born by caesarean were more likely to suﬀer from
obesity at age 23–25 years in comparison to those born
vaginally, even after appropriate adjustments (15% versus
10%) [60]. In the longitudinal 1986 Northern Finland Birth
Cohort study including 4.168 participants, Pirkola et al.
found that infants born from overweight and GDM mothers
had a 40% and 26% higher prevalence for being either over-
weight or having abdominal obesity at the age of 16 years.
This risk was also present in the subgroup of infants born
to overweight mothers who were free of GDM during preg-
nancy [61]. This signiﬁcant impact of maternal obesity on
child obesity at a later age, independent of maternal glycemic
status, was conﬁrmed in other studies [62]. This led us to
speculate that maternal obesity, either directly or through
its associated complications, is a risk factor for increasedExperimental Diabetes Research 5
adiposity and reprogramming of metabolic functions in the
oﬀspring at birth as well as the perpetuation of this increased
adiposity into adulthood.
5.2. Potential Mechanisms for the Long-Term Impacts of
Gestational Obesity on the Oﬀspring
5.2.1. Metabolic and Hormonal Theories. In order to better
understand the fetal programming of increased fat mass
observed in human epidemiological studies, animal model
of maternal obesity was developed. Although not yet well
understood, few mechanisms of action for such long-lasting
eﬀect in oﬀspring were proposed. The most common animal
model is the one using a high-fat diet either during gestation
alone or in combination to lactation period. However, one
question that can be addressed for the validity of this model
in term of similarity with real obesity observed in women is
whether maternal obesity acts as a programming agent per se
or whether other aspects of the obesity-inducing diet drive
the fetal responses. To answer this question, Spraque-Dawley
rats where fed an obesogenic liquid diet by intragastric
cannulation to induce obesity in those dams [63]. At mating
period,damsweretransferredtoacontroldietandthereafter
oﬀered back their obesogenic diet. In order to speciﬁcally
target the intrauterine life as an obesogenic environment,
afterbirth,pupsbornfromobeseanimalswerecross-fostered
to lean dams at birth. In comparison with those born from
lean dams, the oﬀspring of obese dams exhibited increased
adiposity and insulin resistance until postnatal day 130. This
study therefore strongly suggests an independent eﬀect of
maternal obesity, speciﬁcally during the fetal period, on risk
of obesity in the oﬀspring. In line with this study, Bayol
et al. showed in 10-week-old rats born to mothers fed a
westernized high-fat diet throughout the course of gestation
and lactation an exacerbated preference for palatable foods,
at the expense of protein-rich foods, that was accompanied
by increased body weight and fat mass when compared to
control oﬀspring [64]. In these rats, exacerbated adiposity
was accompanied by elevated insulin, glucose, triglycerides
and cholesterol plasma concentrations. Furthermore, a
group of oﬀspring from mothers fed the westernized diet
during pregnancy and lactation were switched to a balanced
chow diet after weaning. In comparison to oﬀspring born
from dams who were never exposed to prenatal junk
food diet, exposed oﬀspring exhibited a relative increase in
perirenal fat pad mass (a visceral fat depot) and adipocyte
hypertrophy, which is believed to reﬂect reduced ability
for adipogenesis and hyperplasia, as well as modulation of
genes involved in glucose and insulin regulation and in
adipose tissue functions [65]. These studies demonstrate
that an obesogenic maternal diet during pregnancy and
lactation may directly contribute to the development of
total body adiposity, adipose tissue dysfunction, central fat
accumulation and metabolic disease later in life.
Obesity,insulinresistance,glucoseintoleranceandmeta-
bolic syndrome were also shown after culling pups to smaller
littersizeduringlactation(F0generation)[66].Generational
transmission of these pathological states, except for obesity,
was observed in the aging oﬀspring born from rats of the F0
generation even though they were not themselves exposed to
overnutrition (F1 generation). In the second generation of
oﬀspring (F2 generation), fasting hyperglycemia and glucose
intolerance were still apparent by 4 months of age [66]. In
mouse as in nonhuman primates, in addition to impairing
adiposity, maternal high-fat diet induces in the oﬀspring
an increase in gluconeogenic enzyme expression [67]o ra
reduction in liver insulin signalling and activation of JNK
and IKK beta [68]. These studies thus provide a mechanism
of action for the fatty liver and insulin resistance observed
in those oﬀspring. In line with the previous observations,
oﬀspring born to dams fed a fat-rich diet throughout gesta-
tion and lactation had a dysfunctional adipose tissue as char-
acterized by impaired adipokines production (leptin, adipo-
nectin) and enzymatic function (lipoprotein lipase and hor-
mone-sensitive lipase). These defaults were worsened when
theoﬀspringwerethemselvesfedthefat-richdietafterwean-
ing [69]. Thus, in utero exposure to maternal obesity and un-
healthy diet pattern per se can program multiple aspects of
energy-balance regulation in the oﬀspring that may be the
leading cause of perpetuated adult metabolic diseases.
5.2.2. The Epigenetic Matter. One possible mechanism by
which obesity and metabolic disturbances can occur in oﬀ-
spring is related to epigenetic modiﬁcations of genes which
may be induced by the in utero environment and result in
gene expression without altering DNA sequences. Epigenetic
changes are deﬁned as the transmission of DNA or RNA
activity without modifying the nucleotide sequence. Epi-
genetic misprogramming during development by maternal
nutrition or by obesity-related metabolic milieu is now
widely thought to have a persistent eﬀect on the develop-
mental plasticity of the foetus leading to obesity-related dis-
eases in children [70]. Studies suggest that maternal obesity,
via a pro-inﬂammatory milieu, insulin resistance, or other
hormonal factors, causes epigenetic programming of the
foetus [3, 71] which predisposes to the development of
obesity and type 2 diabetes mellitus early in life, thus per-
petuating the vicious circle of obesity.
Recently,Plagemannandcolleaguesreportedthatneona-
tal overfeeding by culling pups to smaller litters size during
lactation resulted in early weight gain, obesity, hyperleptine-
mia, hyperglycemia, increased insulin to glucose ratio and
increasedinsulinreceptorpromoter(IRP)methylationinthe
hypothalamus [72]. Moreover, by performing longitudinal
analysis of the data, blood glucose was positively associated
to IRP methylation (r = 0.52; P = 0.04), independently
of group (overfed or control). These data are in accordance
with the observation that one mechanism by which glucose
intolerance could occur in rat oﬀspring exposed to high fat
diet may be through increased hepatic gluconeogenesis and
histone modiﬁcation of the oﬀspring liver Pkc1 gene which
encodes the phosphoenolpyruvate carboxykinase 1 enzyme
[73]. These data thus suggest that obese women carry a
“milieu” that can potentially impair the developing child
epigenomic-associated metabolic status and then lead to
adulthood diseases.6 Experimental Diabetes Research
5.2.3. The Placental Eﬀect. Another possible mechanism by
which maternal nutrition can impact on the oﬀspring may
be through placental eﬀects. Recently, a prospective observa-
tional study using a nonhuman primate model gave impor-
tant insight into the consequences of high-fat diet-induced
maternal obesity. In comparison to control mothers and
independently of their BMI status, those mothers receiving
the high-fat diet had a reduction in uterine blood ﬂow and
increase placental inﬂammation. Furthermore, mothers on
the high-fat diet who developed obesity and displayed signs
ofhyperinsulinemiademonstratedafurtherdecreaseintheir
placental blood ﬂow on the fetal side, thus favouring place-
ntal ischemia and stillbirth [74]. Moreover, when female
C57BL/6 mice were fed a high-fat diet for 1 month prior to
conception and throughout gestation, in addition to devel-
oping obesity and insulin resistance, their placentas lacked
trophoblast cells and showed increased signs of oxidative
stress, as compared to controls [75].
In human pregnancies complicated by obesity, higher
placental pro-inﬂammatory cytokines and higher circulating
IL-6 were measured [76]. Accordingly, it was recently
demonstratedthatexpositionofhumanprimarytrophoblas-
tic cell culture to IL-6 stimulated fatty acid accumulation.
The authors also showed that irrespective of BMI, maternal
3rd-trimester circulating IL-6 levels negatively correlates
with placental lipoprotein lipase enzyme activity thereby de-
creasing fatty acid uptake by the placenta. However, these
last results were not replicated in culture conditions [77].
Moreover, fetal adiposity was positively correlated to mater-
nal IL-6 [78], and adult oﬀspring born to IL-6-deﬁcient
damswereheavier,hadincreasedadiposity,decreasedinsulin
sensitivity and leptin concentration [79]. IL-6-deﬁcient mice
presented reduced leptin concentration in their milk and
wild type cross-fostered to IL-6-deﬁcient mice had increased
weight and adipocyte size and showed altered hypothalamic
gene expression. It can thus be speculated that placental
inﬂammation generated by maternal obesity can contribute
to the metabolic disturbance observed in the oﬀspring.
Collectively, these data associates maternal obesity to fetal
programming of metabolic disease by impaired placental
function.
6. Long-Term Health Effect of Gestational
Diabeteson the Offspring
6.1. Clinical Studies. In addition to maternal obesity, prepre-
gnancy diabetes or GDM has been associated with increased
risk in the oﬀspring of developing later in life obesity, insulin
resistance, and type 2 diabetes [80, 81]. In a large prospective
analysis including mother-infant pairs who were enrolled in
the National Collaborative Perinatal Project, infants born
from GDM mothers were more likely to have elevated birth
weight and presented a higher BMI Z-score at 7 years of age
[82]. In order to further deepen the mechanism by which
GDM induces adiposity in children, a study tested 41 child-
ren born from mothers with GDM, 41 children born from
diabetic fathers (and mother with normal glucose tolerance),
and 548 children born from parents with both normal glu-
cose tolerance (control) [83, 84]. In comparison to control
newborns, those exposed to maternal diabetes were bigger
while those born to diabetic fathers were lighter. Following
up the children at 5 years of age, daughters of diabetic moth-
ers developed larger subscapular and triceps skinfold thick-
nesses and displayed higher insulin concentrations during
the oral glucose tolerance test (OGTT), which was accom-
panied by higher insulin increment. These daughters were
also more prone to develop impaired glucose tolerance in
comparison to control children (18.3% versus 1.7%). At 5
years of age, children of diabetic fathers had similar anthro-
pometric data to controls, but daughters had an increased
prevalence of impaired glucose tolerance (10.5% versus
1.7%).Thisdataleadtheauthorstospeculatethatinchildren
borntodiabeticfather,glucoseintoleranceinlaterlifemaybe
programmed by low birth weight. However, since daughters
of diabetic mothers were characterized both by increased
adiposityandlowerinsulinsensitivity,whichwasnotthecase
for daughters of diabetic fathers, these ﬁndings pinpoint to
the direct inﬂuence of the intrauterine milieu on fetal pro-
gramming of later disease.
Regarding maternal glucose tolerance during pregnancy,
as determined by the 2nd-trimester OGTT, it was found that
the higher the maternal plasma glucose was increased dur
ing the test, the higher the cord plasma glucose to insulin
ratio was decreased in comparison to cord blood of foetuses
born to normoglycemic mothers, but with pro-insulin-to-
insulin ratio maintained stable [85]. These results suggest
that maternal diabetes aﬀect fetal insulin sensibility rather
than β-cell function and that this may lead to altered meta-
bolic function in the children later in life. Accordingly, in a
cohort of 21 children aged between 5 and 10 years, Bush and
colleagues showed that 2nd-trimester glycemic level 1 hour
after a 50g oral glucose load was inversely correlated with
insulin sensitivity assessment during a liquid meal tolerance
test in the children, but positively associated with static β-
cell response and this was independently of adiposity [86].
Taken together, these studies suggest that at a young age,
children who were exposed to high glucose concentrations
during their fetal life develop metabolic dysfunctions with
time. Studies using gold standard techniques for metabolic
assessment and larger cohort are needed to really conclude
on the speciﬁc eﬀects of high maternal glucose on the repro-
gramming of fetal functions.
6.2. Potential Mechanisms for the Long-Term Impacts of
Gestational Diabetes on the Oﬀspring. Animal studies were
alsoconductedinordertopinpointtheinﬂuenceofGDMon
the transgenerational transmission of obesity and diabetes.
In fact, already in the early 90s’, studies performed in
rodents showed that maternal hyperglycemia leads to over-
weight, impaired glucose tolerance, hyperinsulinemia and
insulin resistance in the oﬀspring later in life [87, 88]. Such
metabolic consequences persisted through the F1 and F2
generations [87–89]. In mice, it was recently reported that
these defects were perpetuated to the next generations
through maternal and/or paternal lineages imprinted genesExperimental Diabetes Research 7
[90, 91]. Moreover, Bouchard and colleagues recently de-
monstrated, in placentas of mothers experiencing glucose
intolerance during pregnancy, an inverse relationship bet-
weenmaternalplasmaglucoseconcentration2hoursafteran
OGTT and placental fetal side leptin DNA methylation. In-
creasedplacentalleptinDNAmethylationwasalsoassociated
to lower cord blood leptin mRNA [92]. These results thus
indicate that, as shown for maternal obesity, gestational
hyperglycemiainducesduringfetallifeanepigeneticmodeof
inheritance for the transmission of adulthood obesity and
associated metabolic disturbances.
7. InterventionalStudiesAimed atReducing
the Impact of MaternalObesity and/or
GestationalDiabeteson the Offspring
The question next arising is whether maternal weight loss
(before or during pregnancy) can reverse or at least reduce
the potential burden of obesity on the oﬀspring. Or more
generally, in those mothers who are overweight or obese
and/or develop GDM, how can we reduce the risk of trans-
generational transmission of obesity and diabetes to the
developing child?
In a population of glucose-intolerant subjects, the Dia-
betes Prevention Program (DPP) and the Finnish Diabetes
Prevention Study (DPS) demonstrated the eﬀectiveness of
an intensive program of lifestyle modiﬁcation, which was
accompanied by modest weight loss, in order to prevent
almost 60% of new cases of type 2 diabetes mellitus [93, 94].
Moreover, the American Dietetic Association [95], the
American Society for Nutrition [95], and the British Fertility
Society [96] have all recommended that overweight/obese
women should be provided with assistance to lose weight
prior to conception and maintain a healthy lifestyle to pre-
vent excess weight gain during pregnancy. Furthermore, a
recentreviewoftheliteratureproposedthatimprovedweight
management by adequate nutritional diet may be successful
in preventing GDM in pregnant women [97].
7.1. Lessons from Bariatric Surgery. Consistent with the im-
portance for weight loss, most bariatric surgery has shown
some beneﬁcial [98, 99]e ﬀects on pregnancy outcomes in
obese mothers and their neonates even though it was not the
case in some other studies (as reviewed in [100]). Of note,
bariatric surgery is also likely to aﬀect patients’ eating habits
that contribute to improve obstetrical and neonatal com-
plications in addition to weight loss. One lesson that we
learned from bariatric surgery is that children born to moth-
ers after weight loss due to bariatric surgery had a reduc-
tion in macrosomic prevalence in comparison to the siblings
born before surgery, without diﬀerence in prevalence of low
birth weight [101]. In the children born from a pregnancy
occurringafterthemotherunderwentbariatricsurgery,their
riskofdevelopingobesityintoadulthoodwasgreatlyreduced
[101]. Moreover, in a retrospective study, it was shown that
in women who delivered after a bariatric surgery, the inci-
dence of GDM and caesarean was less than in pregnancies
that occurred before surgery [102]. These data thus imply
that maternal weight loss and improvement of metabolic
state before pregnancy improve obstetrical and neonatal
complications, as well as adulthood-programmed disease in
the oﬀspring.
7.2.LifestyleManagementandWeightControlbeforeorduring
Pregnancy. In the next section, we will present clinical (sum-
marized in Table 2) and animal (summarized in Table 3)
studies that have examined the main interventions tested to
reduce the impact of maternal obesity and gestational dia-
betes and how they can break the vicious circle that per-
petuates the transmission of obesity and metabolic condi-
tions to the next generations.
7.2.1. Clinical Studies. Regarding lifestyle management dur-
ing pregnancy, few studies assessing the role of a dietitan
intervention alone have been published. A randomized con-
trolled trial undertaken in Belgium enrolled 122 obese
pregnant women in 3 groups receiving either nutritional
advice from a brochure; the brochure and lifestyle education
by a dietitian; or no intervention [103]. By assessing dieti-
tian intervention using food log book or questionnaires, the
authors found that while their intervention positively im-
pacted on nutritional habits of participants, it did not result
in any improvement of obstetrical or neonatal outcomes. On
theotherhand,Wolﬀetal.showedthatwhenobesepregnant
women were assisting to frequent nutritional consultation
with a specialized dietitian (ten 1-hour sessions during pre-
gnancy), they gained less gestational weight and reduced
their fasting insulin, glucose and leptin concentrations, thus
suggesting improved metabolic control [104]. However, as
in the previous paper, similar obstetrical and neonatal
complications between intervention and control women
were observed. These studies thus suggest that in order to
achieve more optimal weight gain during pregnancy with
a nutritional approach alone, it seems important that the
participantbeneﬁtsfromindividualizedprofessionaladvices.
The results of studies assessing the beneﬁts of exercise
alone either before and/or during pregnancy are worth men-
tioning. In a small cohort of obese pregnant women, Calla-
way and colleagues showed that even though an increase
in energy expenditure of 900kcal/week was achieved by
28 weeks of gestation with an individualized exercise pro-
gram, HOMA-IR and GDM outcomes were not diﬀerent
in comparison to the group receiving usual care, and the
authors concluded that the eﬃciency of their intervention
was not convincing [105]. Nevertheless, they showed that
by 28 weeks, fasting glucose was signiﬁcantly reduced and
that by 36 weeks, fasting insulin was signiﬁcantly reduced by
28% in mothers of the intervention group, thus suggesting
that these metabolic gains still may show some beneﬁts
on a longer-term basis in their children. Clapp et al. also
found that in women physically active before pregnancy,
those who sustained intensive activity throughout pregnancy
gain less gestational weight than those who stopped physical
activity at the beginning of pregnancy [106]. Moreover, they
showed beneﬁcial eﬀects on the newborns such as reduced
birth weight, ponderal index, percent body fat and fat mass.8 Experimental Diabetes Research
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r
s
u
s
D
g
r
o
u
p
(
P
<
0
.
0
5
)
G
D
M
i
n
c
i
d
e
n
c
e
:
1
s
t
t
r
i
m
e
s
t
e
r
:
s
i
m
i
l
a
r
2
n
d
t
r
i
m
e
s
t
e
r
:
s
i
m
i
l
a
r
i
n
t
e
r
m
o
f
p
r
e
s
c
r
i
p
t
i
o
n
r
e
l
a
t
e
d
t
o
i
n
s
u
l
i
n
t
o
m
a
i
n
t
a
i
n
g
l
u
c
o
s
e
.
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
c
a
e
s
a
r
e
a
n
r
a
t
e
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
f
o
r
m
a
c
r
o
s
o
m
i
a
,
s
m
a
l
l
f
o
r
g
e
s
t
a
t
i
o
n
a
l
a
g
e
a
n
d
b
i
r
t
h
w
e
i
g
h
t
N
/
A
Q
u
i
n
l
i
v
a
n
e
t
a
l
.
,
2
0
1
1
A
u
s
t
N
Z
J
O
b
s
t
e
t
G
y
n
a
e
c
o
l
[
1
0
8
]
n
=
1
2
4
,
o
v
e
r
w
e
i
g
h
t
o
r
o
b
e
s
e
(
B
M
I
>
2
5
)
p
r
e
g
n
a
n
t
w
o
m
e
n
R
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
4
s
t
e
p
s
i
n
d
i
v
i
d
u
a
l
a
p
p
r
o
a
c
h
:
(
1
)
c
o
n
t
i
n
u
i
t
y
o
f
c
a
r
e
p
r
o
v
i
d
e
r
,
(
2
)
w
e
i
g
h
t
i
n
g
a
t
e
a
c
h
v
i
s
i
t
,
(
3
)
b
r
i
e
f
d
i
e
t
a
r
y
i
n
t
e
r
v
e
n
t
i
o
n
b
y
a
f
o
o
d
t
e
c
h
n
o
l
o
g
i
s
t
,
a
n
d
(
4
)
p
s
y
c
h
o
l
o
g
i
c
a
l
s
u
p
p
o
r
t
C
o
n
t
r
o
l
g
r
o
u
p
:
r
o
u
t
i
n
e
c
a
r
e
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
↓
i
n
i
n
t
e
r
v
e
n
t
i
o
n
v
e
r
s
u
s
c
o
n
t
r
o
l
(
P
<
0
.
0
0
1
)
G
D
M
i
n
c
i
d
e
n
c
e
:
↓
i
n
i
n
t
e
r
v
e
n
t
i
o
n
v
e
r
s
u
s
c
o
n
t
r
o
l
(
P
<
0
.
0
4
)
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
N
/
A
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
b
i
r
t
h
w
e
i
g
h
t
N
/
A
K
o
r
p
i
-
H
y
o
v
a
l
t
i
e
t
a
l
.
,
2
0
1
1
B
M
C
P
u
b
l
i
c
h
e
a
l
t
h
[
1
0
9
]
n
=
5
4
,
h
i
g
h
r
i
s
k
f
o
r
G
D
M
p
r
e
g
n
a
n
t
(
8
–
1
2
w
e
e
k
s
)
w
o
m
e
n
i
r
r
e
s
p
e
c
t
i
v
e
o
f
B
M
I
a
t
i
n
c
l
u
s
i
o
n
O
p
e
n
m
u
l
t
i
c
e
n
t
e
r
r
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
i
n
d
i
v
i
d
u
a
l
c
o
u
n
s
e
l
i
n
g
o
n
n
u
t
r
i
t
i
o
n
(
d
i
e
t
i
t
i
a
n
)
a
n
d
p
h
y
s
i
c
a
l
a
c
t
i
v
i
t
y
(
p
h
y
s
i
o
t
h
e
r
a
p
i
s
t
)
C
o
n
t
r
o
l
g
r
o
u
p
:
c
l
o
s
e
f
o
l
l
o
w
u
p
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
s
m
a
l
l
↓
i
n
i
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
(
P
=
0
.
0
6
2
)
G
D
M
i
n
c
i
d
e
n
c
e
:
s
i
m
i
l
a
r
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
h
e
a
v
i
e
r
b
i
r
t
h
w
e
i
g
h
t
(
P
=
0
.
0
4
7
)
;
s
i
m
i
l
a
r
r
a
t
e
s
o
f
m
a
c
r
o
s
o
m
i
a
,
a
d
m
i
s
s
i
o
n
s
t
o
N
I
C
U
a
n
d
r
e
s
p
i
r
a
t
o
r
y
d
i
s
t
r
e
s
s
N
/
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T
a
b
l
e
2
:
C
o
n
t
i
n
u
e
d
.
S
t
u
d
y
P
o
p
u
l
a
t
i
o
n
S
t
u
d
y
d
e
s
i
g
n
I
n
t
e
r
v
e
n
t
i
o
n
M
a
t
e
r
n
a
l
o
u
t
c
o
m
e
s
G
e
s
t
a
t
i
o
n
a
l
o
r
o
b
s
t
e
t
r
i
c
a
l
o
u
t
c
o
m
e
s
N
e
o
n
a
t
a
l
o
u
t
c
o
m
e
s
L
o
n
g
-
t
e
r
m
o
ﬀ
s
p
r
i
n
g
o
u
t
c
o
m
e
s
L
i
n
d
h
o
l
m
e
t
a
l
.
,
2
0
1
0
A
c
t
a
O
b
s
t
e
t
G
y
n
e
c
o
l
S
c
a
n
d
[
1
1
0
]
n
=
2
5
,
o
v
e
r
w
e
i
g
h
t
(
B
M
I
3
0
–
3
5
,
n
=
1
1
)
o
r
o
b
e
s
e
(
B
M
I
>
3
5
,
n
=
1
4
)
p
r
e
g
n
a
n
t
w
o
m
e
n
U
n
c
o
n
t
r
o
l
l
e
d
p
r
o
s
p
e
c
t
i
v
e
i
n
t
e
r
v
e
n
t
i
o
n
s
t
u
d
y
I
n
d
i
v
i
d
u
a
l
c
o
u
n
s
e
l
i
n
g
w
i
t
h
m
i
d
w
i
f
e
e
v
e
r
y
2
w
e
e
k
s
+
2
g
r
o
u
p
s
e
s
s
i
o
n
s
f
r
o
m
1
s
t
t
r
i
m
e
s
t
e
r
t
o
d
e
l
i
v
e
r
y
o
n
d
i
e
t
a
n
d
e
x
e
r
c
i
s
e
.
O
n
e
i
n
i
t
i
a
l
c
o
n
s
u
l
t
a
t
i
o
n
w
i
t
h
d
i
e
t
i
t
i
a
n
G
o
a
l
:
g
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
≤
6
k
g
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
1
4
/
2
5
r
e
a
c
h
e
d
g
o
a
l
s
;
↓
i
n
p
r
e
p
r
e
g
n
a
n
c
y
B
M
I
>
3
5
v
e
r
s
u
s
3
0
–
3
5
(
P
=
0
.
0
0
1
)
G
D
M
i
n
c
i
d
e
n
c
e
:
a
s
e
x
p
e
c
t
e
d
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
i
n
p
r
e
p
r
e
g
n
a
n
c
y
B
M
I
>
3
5
v
e
r
s
u
s
3
0
–
3
5
:
↑
g
e
s
t
a
t
i
o
n
a
l
w
e
e
k
s
(
P
=
0
.
0
4
)
,
↓
c
a
e
s
a
r
e
a
n
(
P
=
0
.
0
4
)
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
f
e
t
a
l
g
r
o
w
t
h
a
n
d
b
i
r
t
h
w
e
i
g
h
t
:
a
s
e
x
p
e
c
t
e
d
N
/
A
S
h
i
r
a
z
i
a
n
e
t
a
l
.
,
2
0
1
0
A
m
J
P
e
r
i
n
a
t
o
l
[
1
1
1
]
n
=
4
1
,
n
o
n
d
i
a
b
e
t
i
c
o
b
e
s
e
(
B
M
I
>
3
0
)
p
r
e
g
n
a
n
t
w
o
m
e
n
P
r
o
s
p
e
c
t
i
v
e
s
t
u
d
y
w
i
t
h
h
i
s
t
o
r
i
c
a
l
c
o
n
t
r
o
l
s
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
i
n
d
i
v
i
d
u
a
l
c
o
u
n
s
e
l
i
n
g
o
n
h
e
a
l
t
h
y
d
i
e
t
a
n
d
e
x
e
r
c
i
s
e
,
≥
5
o
n
e
-
o
n
-
o
n
e
c
o
u
n
s
e
l
l
i
n
g
o
r
p
h
o
n
e
c
a
l
l
s
+
≥
1
s
e
m
i
n
a
r
/
t
r
i
m
e
s
t
e
r
x
/
t
r
i
m
e
s
t
e
r
.
W
e
i
g
h
t
g
a
i
n
g
o
a
l
≤
1
5
l
b
s
.
C
o
n
t
r
o
l
g
r
o
u
p
:
r
o
u
t
i
n
e
c
a
r
e
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
1
/
2
o
f
c
o
n
t
r
o
l
(
P
=
0
.
0
0
3
)
G
D
M
i
n
c
i
d
e
n
c
e
:
s
i
m
i
l
a
r
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
b
i
r
t
h
w
e
i
g
h
t
a
n
d
r
a
t
e
s
o
f
f
e
t
a
l
c
o
m
p
l
i
c
a
t
i
o
n
s
N
/
A
C
r
o
w
t
h
e
r
e
t
a
l
.
,
2
0
0
5
N
E
n
g
l
J
M
e
d
[
1
1
2
]
G
i
l
l
m
a
n
e
t
a
l
.
,
2
0
1
0
D
i
a
b
e
t
e
s
C
a
r
e
[
1
1
3
]
n
=
1
0
0
0
,
m
i
l
d
G
D
M
p
r
e
g
n
a
n
t
w
o
m
e
n
(
m
e
d
i
a
n
B
M
I
=
2
6
)
O
ﬀ
s
p
r
i
n
g
a
g
e
d
4
-
5
y
r
s
:
n
=
9
4
(
i
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
)
;
n
=
1
0
5
(
c
o
n
t
r
o
l
g
r
o
u
p
)
M
u
l
t
i
c
e
n
t
e
r
r
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
A
C
H
O
I
S
s
t
u
d
y
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
i
n
d
i
v
i
d
u
a
l
d
i
e
t
a
r
y
a
n
d
l
i
f
e
s
t
y
l
e
c
o
u
n
s
e
l
i
n
g
,
u
s
u
a
l
G
D
M
c
a
r
e
,
i
n
s
u
l
i
n
t
h
e
r
a
p
y
i
n
2
0
%
o
f
w
o
m
e
n
;
f
r
o
m
r
e
c
r
u
i
t
m
e
n
t
(
2
4
–
3
4
w
e
e
k
g
e
s
t
a
t
i
o
n
)
t
o
d
e
l
i
v
e
r
y
C
o
n
t
r
o
l
g
r
o
u
p
:
r
o
u
t
i
n
e
c
a
r
e
N
o
i
n
t
e
r
v
e
n
t
i
o
n
i
n
c
h
i
l
d
r
e
n
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
↓
i
n
i
n
t
e
r
v
e
n
t
i
o
n
v
e
r
s
u
s
c
o
n
t
r
o
l
(
P
=
0
.
0
1
)
G
D
M
i
n
c
i
d
e
n
c
e
:
s
i
m
i
l
a
r
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
↑
p
o
s
t
p
a
r
t
u
m
q
u
a
l
i
t
y
o
f
l
i
f
e
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
↑
i
n
d
u
c
t
i
o
n
o
f
l
a
b
o
r
(
P
<
0
.
0
0
1
)
,
s
i
m
i
l
a
r
c
a
e
s
a
r
e
a
n
r
a
t
e
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
↓
p
e
r
i
n
a
t
a
l
c
o
m
p
l
i
c
a
t
i
o
n
s
(
P
=
0
.
0
1
)
,
↑
a
d
m
i
s
s
i
o
n
t
o
n
e
o
n
a
t
a
l
n
u
r
s
e
r
y
(
P
=
0
.
0
1
)
,
↓
b
i
r
t
h
w
e
i
g
h
t
(
P
<
0
.
0
0
1
)
,
↓
m
a
c
r
o
s
o
m
i
a
(
<
0
.
0
0
1
)
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
i
n
o
ﬀ
s
p
r
i
n
g
4
-
5
y
.
o
.
,
s
i
m
i
l
a
r
B
M
I
Z
-
s
c
o
r
e
,
a
n
d
p
r
o
p
o
r
t
i
o
n
o
f
B
M
I
≥
8
5
t
h
p
e
r
c
e
n
t
i
l
e
L
a
n
d
o
n
e
t
a
l
.
,
2
0
0
9
N
E
n
g
l
J
M
e
d
[
1
1
4
]
n
=
9
0
0
,
m
i
l
d
G
D
M
p
r
e
g
n
a
n
t
w
o
m
e
n
(
m
e
d
i
a
n
B
M
I
=
3
0
)
M
u
l
t
i
c
e
n
t
e
r
r
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
i
n
d
i
v
i
d
u
a
l
n
u
t
r
i
t
i
o
n
a
l
c
o
u
n
s
e
l
i
n
g
,
u
s
u
a
l
G
D
M
c
a
r
e
,
i
n
s
u
l
i
n
t
h
e
r
a
p
y
(
r
e
q
u
i
r
e
d
i
n
3
7
w
o
m
e
n
)
;
f
r
o
m
r
e
c
r
u
i
t
m
e
n
t
(
2
4
–
3
1
w
e
e
k
s
)
t
o
d
e
l
i
v
e
r
y
C
o
n
t
r
o
l
g
r
o
u
p
:
r
o
u
t
i
n
e
c
a
r
e
,
i
n
s
u
l
i
n
t
h
e
r
a
p
y
(
r
e
q
u
i
r
e
d
i
n
2
w
o
m
e
n
)
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
↓
i
n
i
n
t
e
r
v
e
n
t
i
o
n
v
e
r
s
u
s
c
o
n
t
r
o
l
(
P
<
0
.
0
0
1
)
.
G
D
M
i
n
c
i
d
e
n
c
e
:
N
/
A
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
a
c
h
i
e
v
e
m
e
n
t
o
f
m
a
t
e
r
n
a
l
g
l
u
c
o
s
e
t
a
r
g
e
t
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
↓
c
a
e
s
a
r
e
a
n
(
P
=
0
.
0
1
)
,
s
h
o
u
l
d
e
r
d
y
s
t
o
c
i
a
(
P
=
0
.
0
2
)
,
p
r
e
e
c
l
a
m
p
s
i
a
,
o
r
h
y
p
e
r
t
e
n
s
i
o
n
(
P
=
0
.
0
1
)
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
↓
b
i
r
t
h
w
e
i
g
h
t
(
P
<
0
.
0
0
1
)
,
m
a
c
r
o
s
o
m
i
a
(
P
<
0
.
0
0
1
)
,
f
a
t
m
a
s
s
(
P
=
0
.
0
0
3
)
;
s
i
m
i
l
a
r
p
e
r
i
n
a
t
a
l
c
o
m
p
l
i
c
a
t
i
o
n
s
,
s
m
a
l
l
f
o
r
g
e
s
t
a
t
i
o
n
a
l
a
g
e
,
a
d
m
i
s
s
i
o
n
s
t
o
N
I
C
U
,
a
n
d
r
e
s
p
i
r
a
t
o
r
y
d
i
s
t
r
e
s
s
N
/
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T
a
b
l
e
2
:
C
o
n
t
i
n
u
e
d
.
S
t
u
d
y
P
o
p
u
l
a
t
i
o
n
S
t
u
d
y
d
e
s
i
g
n
I
n
t
e
r
v
e
n
t
i
o
n
M
a
t
e
r
n
a
l
o
u
t
c
o
m
e
s
G
e
s
t
a
t
i
o
n
a
l
o
r
o
b
s
t
e
t
r
i
c
a
l
o
u
t
c
o
m
e
s
N
e
o
n
a
t
a
l
o
u
t
c
o
m
e
s
L
o
n
g
-
t
e
r
m
o
ﬀ
s
p
r
i
n
g
o
u
t
c
o
m
e
s
G
a
r
n
e
r
e
t
a
l
.
,
1
9
9
7
A
m
J
O
b
s
t
e
t
G
y
n
e
c
o
l
[
1
1
5
]
A
n
d
M
a
l
c
o
l
m
e
t
a
l
.
,
2
0
0
6
D
i
a
b
e
t
M
e
d
[
1
1
6
]
n
=
3
0
0
,
l
o
w
-
r
i
s
k
p
r
e
g
n
a
n
t
(
2
4
–
3
2
w
e
e
k
s
)
w
o
m
e
n
w
i
t
h
G
D
M
O
ﬀ
s
p
r
i
n
g
a
g
e
d
7
–
1
1
y
r
s
:
n
=
4
6
(
i
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
)
,
n
=
2
5
(
c
o
n
t
r
o
l
g
r
o
u
p
)
R
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
I
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
:
i
n
d
i
v
i
d
u
a
l
d
i
e
t
a
r
y
c
o
u
n
s
e
l
i
n
g
b
y
d
i
e
t
i
t
i
a
n
b
i
w
e
e
k
l
y
,
u
s
u
a
l
G
D
M
c
a
r
e
,
i
n
s
u
l
i
n
t
h
e
r
a
p
y
(
r
e
q
u
i
r
e
d
i
n
3
6
w
o
m
e
n
)
C
o
n
t
r
o
l
g
r
o
u
p
:
n
o
t
s
e
e
n
b
y
d
i
e
t
i
t
i
a
n
;
r
e
c
o
m
m
e
n
d
e
d
t
o
e
a
t
u
n
r
e
s
t
r
i
c
t
e
d
l
y
a
c
c
o
r
d
i
n
g
t
o
C
a
n
a
d
a
f
o
o
d
g
u
i
d
e
;
b
i
w
e
e
k
l
y
s
e
l
f
-
g
l
u
c
o
s
e
m
o
n
i
t
o
r
i
n
g
N
o
i
n
t
e
r
v
e
n
t
i
o
n
i
n
c
h
i
l
d
r
e
n
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
s
i
m
i
l
a
r
G
D
M
i
n
c
i
d
e
n
c
e
:
s
i
m
i
l
a
r
O
G
T
T
a
r
e
a
u
n
d
e
r
t
h
e
c
u
r
v
e
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
a
t
2
8
–
3
0
w
e
e
k
s
:
↑
p
r
e
p
r
a
n
d
i
a
l
g
l
u
c
o
s
e
l
e
v
e
l
s
(
P
=
0
.
0
0
1
)
a
t
3
6
–
3
8
w
e
e
k
s
:
↓
p
r
e
p
r
a
n
d
i
a
l
(
P
=
0
.
0
3
5
)
a
n
d
1
-
h
o
u
r
p
o
s
t
p
r
a
n
d
i
a
l
(
P
=
0
.
0
0
9
)
g
l
u
c
o
s
e
l
e
v
e
l
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
c
a
e
s
a
r
e
a
n
r
a
t
e
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
b
i
r
t
h
w
e
i
g
h
t
,
p
e
r
i
n
a
t
a
l
c
o
m
p
l
i
c
a
t
i
o
n
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
s
i
m
i
l
a
r
m
e
a
n
f
a
s
t
i
n
g
g
l
u
c
o
s
e
,
m
e
a
n
f
a
s
t
i
n
g
i
n
s
u
l
i
n
,
a
n
d
m
e
a
n
2
h
r
s
g
l
u
c
o
s
e
a
n
d
i
n
s
u
l
i
n
;
5
c
h
i
l
d
r
e
n
b
o
r
n
t
o
m
o
t
h
e
r
s
f
r
o
m
i
n
t
e
r
v
e
n
t
i
o
n
g
r
o
u
p
h
a
d
A
G
T
M
o
s
e
s
e
t
a
l
.
,
2
0
0
6
A
m
J
C
l
i
n
N
u
t
r
[
1
1
7
]
n
=
7
0
,
p
r
e
g
n
a
n
t
(
1
2
–
1
6
w
e
e
k
s
)
w
o
m
e
n
∗
P
a
r
t
i
c
i
p
a
n
t
s
w
i
t
h
c
o
n
d
i
t
i
o
n
s
a
s
s
o
c
i
a
t
e
d
t
o
a
b
n
o
r
m
a
l
g
l
u
c
o
s
e
m
e
t
a
b
o
l
i
s
m
a
n
d
i
n
s
u
l
i
n
r
e
s
i
s
t
a
n
c
e
p
r
o
b
l
e
m
w
e
r
e
e
x
c
l
u
d
e
d
R
a
n
d
o
m
i
z
e
d
c
o
n
t
r
o
l
l
e
d
t
r
i
a
l
N
o
c
o
n
t
r
o
l
g
r
o
u
p
w
i
t
h
o
u
t
i
n
t
e
r
v
e
n
t
i
o
n
L
o
w
-
g
l
y
c
e
m
i
c
i
n
d
e
x
g
r
o
u
p
:
i
n
d
i
v
i
d
u
a
l
n
u
t
r
i
t
i
o
n
a
l
c
o
u
n
s
e
l
i
n
g
b
y
d
i
e
t
i
t
i
a
n
5
t
i
m
e
s
d
u
r
i
n
g
p
r
e
g
n
a
n
c
y
o
n
r
e
c
o
m
m
e
n
d
e
d
n
u
t
r
i
t
i
o
n
a
l
i
n
t
a
k
e
p
l
u
s
l
o
w
-
g
l
y
c
e
m
i
c
i
n
d
e
x
d
i
e
t
H
i
g
h
-
g
l
y
c
e
m
i
c
i
n
d
e
x
g
r
o
u
p
:
i
d
e
m
e
x
c
e
p
t
f
o
r
r
e
c
o
m
m
e
n
d
a
t
i
o
n
o
f
h
i
g
h
-
g
l
y
c
e
m
i
c
i
n
d
e
x
d
i
e
t
G
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
:
s
i
m
i
l
a
r
G
D
M
i
n
c
i
d
e
n
c
e
:
s
i
m
i
l
a
r
(
o
n
l
y
1
c
a
s
e
)
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
i
n
l
o
w
v
e
r
s
u
s
h
i
g
h
-
g
l
y
c
e
m
i
c
i
n
d
e
x
g
r
o
u
p
:
↓
g
l
y
c
e
m
i
c
i
n
d
e
x
(
P
<
0
.
0
0
1
)
,
f
a
s
t
i
n
g
g
l
u
c
o
s
e
(
P
=
0
.
0
3
4
)
W
i
t
h
i
n
l
o
w
-
g
l
y
c
e
m
i
c
i
n
d
e
x
g
r
o
u
p
:
↓
f
a
s
t
i
n
g
g
l
u
c
o
s
e
(
P
=
0
.
0
0
1
)
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
i
n
l
o
w
-
v
e
r
s
u
s
h
i
g
h
-
g
l
y
c
e
m
i
c
i
n
d
e
x
g
r
o
u
p
:
s
i
m
i
l
a
r
c
a
e
s
a
r
e
a
n
r
a
t
e
s
I
n
t
e
r
v
e
n
t
i
o
n
i
m
p
a
c
t
:
i
n
l
o
w
-
v
e
r
s
u
s
h
i
g
h
-
g
l
y
c
e
m
i
c
i
n
d
e
x
g
r
o
u
p
:
↓
b
i
r
t
h
w
e
i
g
h
t
(
P
=
0
.
0
5
1
)
,
m
a
c
r
o
s
o
m
i
a
(
P
=
0
.
0
0
1
)
,
p
o
n
d
e
r
a
l
i
n
d
e
x
(
P
=
0
.
0
3
)
;
s
i
m
i
l
a
r
p
e
r
i
n
a
t
a
l
c
o
m
p
l
i
c
a
t
i
o
n
s
,
s
m
a
l
l
f
o
r
g
e
s
t
a
t
i
o
n
a
l
a
g
e
,
a
d
m
i
s
s
i
o
n
s
t
o
N
I
C
U
,
r
e
s
p
i
r
a
t
o
r
y
d
i
s
t
r
e
s
s
N
/
A
A
C
H
O
I
S
:
A
u
s
t
r
a
l
i
a
n
C
a
r
b
o
h
y
d
r
a
t
e
I
n
t
o
l
e
r
a
n
c
e
i
n
P
r
e
g
n
a
n
t
W
o
m
e
n
s
t
u
d
y
,
A
G
T
:
a
b
n
o
r
m
a
l
g
l
u
c
o
s
e
t
o
l
e
r
a
n
c
e
,
B
M
I
:
b
o
d
y
m
a
s
s
i
n
d
e
x
,
G
D
M
:
g
e
s
t
a
t
i
o
n
a
l
d
i
a
b
e
t
e
s
m
e
l
l
i
t
u
s
,
M
E
T
:
m
e
t
a
b
o
l
i
c
e
q
u
i
v
a
l
e
n
t
t
a
s
k
,
N
I
C
U
:
n
e
o
n
a
t
a
l
i
n
t
e
n
s
i
v
e
c
a
r
e
u
n
i
t
,
N
/
A
:
n
o
t
a
p
p
l
i
c
a
b
l
e
,
O
G
T
T
:
o
r
a
l
g
l
u
c
o
s
e
t
o
l
e
r
a
n
c
e
t
e
s
t
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T
a
b
l
e
3
:
M
o
s
t
i
m
p
o
r
t
a
n
t
i
n
t
e
r
v
e
n
t
i
o
n
s
p
e
r
f
o
r
m
e
d
i
n
p
r
e
g
n
a
n
t
a
n
i
m
a
l
s
t
o
r
e
d
u
c
e
o
r
i
m
p
r
o
v
e
m
a
t
e
r
n
a
l
,
n
e
o
n
a
t
a
l
,
a
n
d
o
ﬀ
s
p
r
i
n
g
o
u
t
c
o
m
e
s
.
S
t
u
d
y
A
n
i
m
a
l
m
o
d
e
l
I
n
t
e
r
v
e
n
t
i
o
n
M
a
t
e
r
n
a
l
o
u
t
c
o
m
e
s
G
e
s
t
a
t
i
o
n
a
l
o
r
o
b
s
t
e
t
r
i
c
a
l
o
u
t
c
o
m
e
s
N
e
o
n
a
t
a
l
o
u
t
c
o
m
e
s
L
o
n
g
-
t
e
r
m
o
ﬀ
s
p
r
i
n
g
o
u
t
c
o
m
e
D
o
l
i
n
o
y
e
t
a
l
.
,
2
0
0
6
E
n
v
i
r
o
n
H
e
a
l
t
h
P
e
r
s
p
e
c
t
[
1
1
9
]
H
e
t
e
r
o
z
y
g
o
u
s
v
i
a
b
l
e
y
e
l
l
o
w
a
g
o
u
t
i
(
A
v
y
)
m
i
c
e
n
=
1
5
,
u
n
s
u
p
p
l
e
m
e
n
t
e
d
l
i
t
t
e
r
s
(
5
2
o
ﬀ
s
p
r
i
n
g
)
n
=
1
2
,
g
e
n
i
s
t
e
i
n
s
u
p
p
l
e
m
e
n
t
e
d
(
4
4
o
ﬀ
s
p
r
i
n
g
)
F
e
m
a
l
e
s
(
8
–
1
0
w
e
e
k
s
o
f
a
g
e
)
r
e
c
e
i
v
e
d
p
h
y
t
o
e
s
t
r
o
g
e
n
-
f
r
e
e
m
o
d
i
ﬁ
e
d
A
I
N
-
9
3
G
d
i
e
t
o
r
m
o
d
i
ﬁ
e
d
A
I
N
-
9
3
G
d
i
e
t
s
u
p
p
l
e
m
e
n
t
e
d
w
i
t
h
2
5
0
m
g
/
k
g
o
f
g
e
n
i
s
t
e
i
n
(
c
o
m
p
a
r
a
b
l
e
t
o
h
u
m
a
n
h
i
g
h
-
s
o
y
d
i
e
t
)
D
i
e
t
p
r
o
v
i
d
e
d
2
w
e
e
k
s
b
e
f
o
r
e
m
a
t
i
n
g
,
t
h
r
o
u
g
h
o
u
t
p
r
e
g
n
a
n
c
y
a
n
d
l
a
c
t
a
t
i
o
n
N
/
A
N
/
A
D
a
y
2
1
:
s
i
m
i
l
a
r
l
i
t
t
e
r
s
i
z
e
,
w
e
a
n
w
e
i
g
h
t
,
p
e
r
c
e
n
t
s
u
r
v
i
v
a
l
,
s
e
x
r
a
t
i
o
;
m
a
t
e
r
n
a
l
s
u
p
p
l
e
m
e
n
t
a
t
i
o
n
f
a
v
o
r
e
d
p
s
e
u
d
o
a
g
o
u
t
i
v
e
r
s
u
s
f
u
l
l
a
g
o
u
t
i
(
y
e
l
l
o
w
c
o
a
t
)
p
h
e
n
o
t
y
p
e
(
P
=
0
.
0
0
0
5
)
+
↑
A
g
o
u
t
i
g
e
n
e
m
e
t
h
y
l
a
t
i
o
n
A
g
o
u
t
i
g
e
n
e
m
e
t
h
y
l
a
t
i
o
n
h
i
g
h
l
y
c
o
r
r
e
l
a
t
e
d
b
e
t
w
e
e
n
d
a
y
2
1
a
n
d
1
5
0
i
n
o
ﬀ
s
p
r
i
n
g
w
h
o
s
e
m
o
t
h
e
r
s
r
e
c
e
i
v
e
d
s
u
p
p
l
e
m
e
n
t
A
t
w
e
e
k
6
0
:
↓
w
e
i
g
h
t
i
n
p
s
e
u
d
o
a
g
o
u
t
i
v
e
r
s
u
s
f
u
l
l
a
g
o
u
t
i
m
i
c
e
(
P
=
0
.
0
0
0
1
)
P
s
e
u
d
o
a
g
o
u
t
i
:
n
o
r
m
a
l
w
e
i
g
h
t
v
e
r
s
u
s
f
u
l
l
a
g
o
u
t
i
(
m
o
r
e
o
b
e
s
e
)
S
e
n
e
t
a
l
.
,
2
0
1
0
D
i
a
b
e
t
e
s
[
1
2
0
]
F
e
m
a
l
e
S
p
r
a
g
u
e
-
D
a
w
l
e
y
r
a
t
s
D
i
e
t
s
:
c
o
n
t
r
o
l
(
C
,
n
=
1
0
)
;
c
o
n
t
r
o
l
+
a
n
t
i
o
x
i
d
a
n
t
(
C
A
o
x
,
n
=
1
0
)
;
W
e
s
t
e
r
n
(
W
,
n
=
1
0
)
,
h
i
g
h
p
r
o
t
e
i
n
+
f
a
t
(
H
P
+
F
,
n
=
1
0
)
;
W
+
A
o
x
(
W
A
o
x
,
n
=
1
0
)
F
e
m
a
l
e
r
a
t
s
r
e
c
e
i
v
e
d
d
i
e
t
s
f
r
o
m
a
g
e
4
t
o
1
3
–
1
5
w
e
e
k
s
(
e
n
d
o
f
g
e
s
t
a
t
i
o
n
)
.
L
i
t
t
e
r
s
c
u
l
l
e
d
t
o
8
p
u
p
s
.
S
t
u
d
i
e
s
p
e
r
f
o
r
m
e
d
i
n
m
a
l
e
o
ﬀ
s
p
r
i
n
g
o
n
l
y
.
A
t
w
e
a
n
i
n
g
,
o
ﬀ
e
r
e
d
c
o
n
t
r
o
l
d
i
e
t
.
E
n
d
o
f
g
e
s
t
a
t
i
o
n
:
↑
g
e
s
t
a
t
i
o
n
a
l
w
e
i
g
h
t
g
a
i
n
i
n
d
a
m
s
o
ﬀ
e
r
e
d
W
a
n
d
W
A
o
x
v
e
r
s
u
s
C
;
s
i
m
i
l
a
r
g
l
u
c
o
s
e
a
n
d
f
o
o
d
c
o
n
s
u
m
p
t
i
o
n
;
↑
i
n
s
u
l
i
n
,
f
r
e
e
-
f
a
t
t
y
a
c
i
d
(
F
F
A
)
a
n
d
l
e
p
t
i
n
i
n
W
v
e
r
s
u
s
C
,
b
u
t
↓
i
n
W
A
o
x
v
e
r
s
u
s
W
N
/
A
E
m
b
r
y
o
s
:
i
n
W
v
e
r
s
u
s
C
:
↑
o
x
i
d
a
t
i
v
e
s
t
r
e
s
s
,
↓
i
n
W
A
o
x
B
i
r
t
h
:
s
i
m
i
l
a
r
w
e
i
g
h
t
I
n
W
v
e
r
s
u
s
C
:
↑
F
F
A
,
i
n
s
u
l
i
n
a
n
d
l
e
p
t
i
n
2
w
e
e
k
s
:
i
n
W
v
e
r
s
u
s
C
:
↑
f
a
t
m
a
s
s
,
F
F
A
,
i
n
s
u
l
i
n
,
l
e
p
t
i
n
,
p
r
o
a
d
i
p
o
g
e
n
i
c
,
a
n
d
l
i
p
o
g
e
n
i
c
g
e
n
e
s
e
x
p
r
e
s
s
i
o
n
,
b
u
t
↓
i
n
W
A
o
x
v
e
r
s
u
s
W
2
m
o
n
t
h
s
:
i
n
W
v
e
r
s
u
s
C
:
↑
t
o
t
a
l
a
n
d
c
e
n
t
r
a
l
f
a
t
m
a
s
s
,
i
n
s
u
l
i
n
,
l
e
p
t
i
n
,
p
r
o
a
d
i
p
o
g
e
n
i
c
a
n
d
l
i
p
o
g
e
n
i
c
g
e
n
e
s
e
x
p
r
e
s
s
i
o
n
,
b
u
t
↓
i
n
W
A
o
x
v
e
r
s
u
s
W
;
↑
i
m
p
a
i
r
e
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Moreover, these beneﬁts were maintained at 5 years of age
as these children had reduced weight, ponderal index and
skinfolds as well as presented improved neurodevelopmental
skills. A recent paper reviewing prospective, retrospective
and cross-sectional studies assessing prepregnancy and early
pregnancy physical activity in over 35.000 and 4.400 par-
ticipants, respectively, suggested that these women were at
reduced risk of GDM [118].
Other trials aimed to improve maternal, neonatal and
long-term oﬀspring outcomes by lifestyle management.
Indeed, it was shown by Artal and colleagues that, in obese
women with GDM, the addition of physical activity to
improved dietary habits resulted in less gestational gain
weight when compared to the eﬀect of diet alone, without
compromising neonatal outcomes [107]. Quinlivan and col-
leagues performed a randomized-controlled trial enrolling
overweight or obese Australian pregnant participants allo-
cated to standard care or a 4-step approach consisting of
a visit with an interdisciplinary team including: (1) an
obstetrician for continuity of maternal care, (2) a food
technologist for nutritional habits and for providing food
information, (3) a nurse performing weight measurements
and (4) a psychologist to evaluate signs of depression and
anxiety [108]. This interdisciplinary lifestyle intervention
lead to a signiﬁcant reduction in gestational weight gain (7.0
versus 13.8kg) and in the incidence of GDM (6 versus 29%),
as compared to standard care. In spite of these clinically sig-
niﬁcant diﬀerences in obstetrical outcomes, neonate weights
were similar between the 2 groups. Similarly, a group of
Finland’s pregnant women at risk for GDM, based on the
results of an OGTT performed during ﬁrst trimester, were
randomised to the intervention group, consisting of dietary
and physical activity counselling, or in the control group
[109]. Weight gain was slightly, although not signiﬁcantly,
reduced in the intervention group (11.4 versus 13.9; P =
0.06), but no diﬀerence was observed between groups
regarding glucose tolerance during 2nd trimester. However,
although obstetrical and neonatal outcomes were similar
betweengroups,theyshowedaslight,butsigniﬁcantincrease
birthweightintheinterventionversusclosefollow-upgroup.
Other studies have shown that lifestyle improvement by
nutritional or physical activity behavioural modiﬁcations
during pregnancy resulted in recommended gestational
weight gain or lower gain than with control intervention
[110, 111]. Altogether, these trials and others (including
review [122] and meta-analysis [123] )s u g g e s tt h a ti ti sf e a -
sible to improve weight management and/or the metabolic
state of obese or at-risk women during pregnancy, without
negative impact on fetal outcomes. However, results are
somewhat scarce, controversial and inconsistent regarding
the impact on maternal and fetal medical complications,
and long-term follow-up studies are lacking in order to
determine whether they have long lasting metabolic beneﬁts
on the oﬀspring.
The beneﬁts of controlling adequately maternal hyper-
glycemiaduringpregnancyarenowwellestablishedandhave
inﬂuenced international guidelines on the diagnosis and
treatment of gestational hyperglycaemic disorders. The
Australian Carbohydrate Intolerance in Pregnant Women
(ACHOIS) study showed that in women with mild impaired
glucose tolerance but treated with dietary advices and if
needed, insulin, macrosomia incidence and serious neonatal
complications were signiﬁcantly reduced as compared to
the routine care group [112]. However, intervention was
associated with higher admission to neonatal care unit and
increased rate of labor induction although caesarean rate
were similar. This intervention was not associated with any
change in BMI in children at 4-5 years of age between groups
[113]. In a randomized controlled trial held in the US,
Landonandcolleaguesshowedsimilarresultsinwomenwith
mild gestational diabetes enrolled in the intervention group
consisting of a dietary intervention, self-monitoring of blood
glucose and, if needed, insulin therapy [114]. In comparison
to control group who received usual care, the intervention
did not result in improved neonatal complications as in
the ACHOIS study, but it resulted in better fetal growth,
as shown by reduced incidence of macrosomia, large-for-
gestational age as well as fetal fat mass [114]. Unlike the
ACHOIS study, this trial found a reduction in preeclampsia,
caesarean and shoulder dystocia. Results of the long-term
follow-up of the oﬀspring are not yet available. However, in
71 children assessed between 7–11 years of age, Malcolm and
colleagues found that interventions in women with gesta-
tional diabetes aiming for either minimal or tight glycemic
control during pregnancy [115]w e r ee q u a l l ye ﬀective for the
prevention of impaired glucose tolerance [116]. However,
this conclusion needs to be interpreted with caution because
no control group was included and this study was limited by
its relatively small sample size.
Since carbohydrates are the main determinant of post-
prandial blood glucose level [124], intervention trials were
assessed or are presently being held to establish the eﬀect
of low glycemic index diet during pregnancy on neonatal
outcomes [125, 126]. Accordingly, one interventional study
conducted in healthy pregnant women proposed that low
glycemic index diet reduces the incidence of macrosomia
[117]. In pregnancies complicated by GDM, it is generally
accepted that a low glycemic index diet is indicated because
it was shown to facilitate glucose control without compro-
mising obstetric and fetal outcomes [127, 128]. In a recent
systematic review of literature on low glycemic index diet,
Louie et al. proposed that until results of larger randomised
control trials are available, low glycemic index diet should
not be introduced into clinical practice, except for mothers
with GDM, because data are not consistent and supported
by large cohorts [129].
In brief, these clinical intervention trials showed some
beneﬁts in terms of improved gestational weight gain but
few provided convincing data for better impact on the
neonates.However,limitationsincludemainlysmallnumber
of participants (lack of power) and possible publication
bias. As it is otherwise satisfactory to observe that these
interventions were not detrimental to the fetus, the next
question arising is whether they have a long lasting impact
on later childhood obesity or metabolic function.
7.2.2.AnimalStudies. Althoughtheimpactofgestationalob-
esity and diabetes on the oﬀspring is well described, humanExperimental Diabetes Research 15
trials conducted to determine whether maternal interven-
tions could break down the vicious cycle on future genera-
tion are still at their infancy. Therefore, only animal studies
can help us to make some inferences for the moment. In fact,
the potential beneﬁcial impact of nutritional intervention
were reported in the yellow Agouti mice and in rats born to
fat-fed mothers. In the yellow Agouti mice, authors showed
that in utero exposure to the dietary antioxidant genistein,
at levels present in human adult populations consuming
high-soy diets, reduces obesity by altering the epigenome in
those mice [119]. In addition, oﬀspring born from dams
fed a fat Westernized diet developed by 2 weeks of age
greater adiposity and glucose intolerance than those born
from dams fed the control diet [120]. However, oﬀspring
born from dams fed the Westernized diet and supplemented
with antioxidant normalized their fat mass as well as their
leptin, glucose, insulin and non-esteriﬁed fatty acid blood
concentrations to levels similar to the control group.
Zambrano and colleague showed that giving a normal
chow to obese female rats 1 months prior to mating and
throughout pregnancy and lactation in comparison to obese
rats who were kept on the obesogenic diet throughout entire
study period resulted in dams with lower gestational weight
gain but in oﬀspring of similar phenotype and weight from
birth to 150 days of age [121]. These results are in agree-
ment with the previously reported literature in human
where maternal interventions with the aim to reduce gesta-
tional weight gain had no eﬀect on the foetuses birth weight.
However, by 21 days of age, oﬀspring born to mothers
on the intervention arm signiﬁcantly improved their high
fat mass, hypertriglyceridemia, hyperleptinemia, hyperinsu-
linemia and insulin resistance, in comparison to rats born
from untreated obese dams, and almost to the same levels
as in rats born from non-obese dams. By 150 days of age,
improvements in leptinemia, fat mass and adipocyte cell size
were still observable [121].
These results suggest that maternal intervention aimed at
reducinggestationalweightgainhastremendouslonglasting
metabolic eﬀects on the oﬀspring, even if fetal and neonatal
proﬁle were similar or slightly changed. It is therefore possi-
ble to extrapolate that even though interventions in humans
did not result in improved newborn phenotype, beneﬁ-
cial eﬀects on the intrauterine milieu may have long lasting
eﬀect on adulthood health of the oﬀspring.
8. Conclusion
In summary, obesity is a common and growing condition
aﬀecting women health. Accordingly, women are more likely
to enter pregnancy being overweight and often exceed the
recommended gestational weight gain. As one major weight-
associated complication, GDM may lead to profound and
long lasting eﬀect in the child. Moreover, even without the
development of GDM, gestational maternal weight increas-
es the future risk of cardiometabolic conditions in the oﬀ-
spring. Fetal programming of metabolic function induced
by obesity and GDM may have intergenerational eﬀect and
thus, perpetuate the burden of such conditions. Mechanisms
by which reprogramming of fetal function might occur is
directly through maternal metabolic and hormonal eﬀects,
epigenetic alterations or impaired placental function. Peri-
conceptional weight loss interventions have demonstrated
their ability to reverse the impacts of maternal obesity and
GDM on the child and are of great importance for the pre-
vention of future cardiometabolic risks in the oﬀspring, and
may thus be the best approach to break the vicious circle of
intergenerational propagation of obesity and diabetes. How-
ever, the nature and the timing of intervention should be
carefully considered because it could also by itself induce
organ reprogramming and potential long-term eﬀect on the
oﬀspring [130, 131]. In addition, larger cohorts and long-
term randomized controlled trials are necessary to provide
robust conclusions.
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